Olive Leaf Extract Shows Elastin-Preserving Effects in Post-Menopausal Skin

Post-menopausal skin loses collagen at a documented rate of 2.1% per year for over a decade. Less discussed is what happens to elastin—the protein responsible for the skin’s recoil, its ability to spring back after movement. An olive leaf extract called Bonolive, developed by Solabia Nutrition, has published clinical data showing targeted elastin preservation effects in post-menopausal women, adding a dimension to the ingestible beauty conversation that collagen peptides alone don’t address.

The Ingredient

Bonolive is an olive leaf extract standardized for oleuropein, the predominant polyphenol in olive leaves (distinct from the hydroxytyrosol and oleocanthal more commonly found in olive oil). Oleuropein activates specific pathways in dermal fibroblasts that upregulate elastin synthesis. It also inhibits matrix metalloproteinase (MMP) activity—reducing the enzymatic breakdown of both elastin and collagen—and provides antioxidant protection against ROS-driven structural protein degradation.

Clinical Findings

NutraIngredients’ February 2026 review of beauty-from-within supplement science documented Bonolive’s clinical data showing improvements in skin microstructure, elastin-related markers, and markers of cellular aging reduction in post-menopausal women. The ingredient specifically distinguishes itself from collagen-focused ingestibles by targeting the elastic fiber network, which degrades alongside collagen but through somewhat different enzymatic and oxidative mechanisms.

Why Elastin Needs Its Own Strategy

Most ingestible beauty products address collagen. The clinical literature on oral collagen peptides, while robust, focuses on collagen precursor supply and fibroblast stimulation for collagen specifically. Elastin’s synthesis pathway is regulated differently—it responds to different growth factors and cytokine signals, and its degradation is driven by distinct elastase enzymes.

After menopause, elasticity declines by 1.5% annually alongside the collagen loss. Products that address only collagen are solving part of the structural problem. The elastin network, which gives skin its characteristic resilience rather than just its thickness, requires targeted support.

The Non-Hormonal Option

HRT improves both collagen and elastin metrics. For women who are not candidates for or choose not to use hormone therapy, plant polyphenols that interact with fibroblast biology through separate pathways—like oleuropein—represent an evidence-building category. Bonolive holds safety data registered with EFSA (European Food Safety Authority) and is applicable in both oral supplement and functional food formats.

The combination of collagen peptides and elastin-targeted ingredients is emerging as the more complete approach in the 2026 post-menopausal skin supplement space, compared to either ingredient category alone.

Sources

NutraIngredients - Catching up with beauty-from-within supplement science